Unknown

Dataset Information

0

Nociceptin/orphanin FQ receptor agonists attenuate L-DOPA-induced dyskinesias.


ABSTRACT: In the present study we investigated whether the neuropeptide nociceptin/orphanin FQ (N/OFQ), previously implicated in the pathogenesis of Parkinson's disease, also affects L-DOPA-induced dyskinesia. In striatal slices of naive rodents, N/OFQ (0.1-1 ?m) prevented the increase of ERK phosphorylation and the loss of depotentiation of synaptic plasticity induced by the D1 receptor agonist SKF38393 in spiny neurons. In vivo, exogenous N/OFQ (0.03-1 nmol, i.c.v.) or a synthetic N/OFQ receptor agonist given systemically (0.01-1 mg/Kg) attenuated dyskinesias expression in 6-hydroxydopamine hemilesioned rats primed with L-DOPA, without causing primary hypolocomotive effects. Conversely, N/OFQ receptor antagonists worsened dyskinesia expression. In vivo microdialysis revealed that N/OFQ prevented dyskinesias simultaneously with its neurochemical correlates such as the surge of nigral GABA and glutamate, and the reduction of thalamic GABA. Regional microinjections revealed that N/OFQ attenuated dyskinesias more potently and effectively when microinjected in striatum than substantia nigra (SN) reticulata, whereas N/OFQ receptor antagonists were ineffective in striatum but worsened dyskinesias when given in SN. Quantitative autoradiography showed an increase in N/OFQ receptor binding in striatum and a reduction in SN of both unprimed and dyskinetic 6-hydroxydopamine rats, consistent with opposite adaptive changes of N/OFQ transmission. Finally, the N/OFQ receptor synthetic agonist also reduced dyskinesia expression in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated dyskinetic macaques without affecting the global parkinsonian score. We conclude that N/OFQ receptor agonists may represent a novel strategy to counteract L-DOPA-induced dyskinesias. Their action is possibly mediated by upregulated striatal N/OFQ receptors opposing the D1 receptor-mediated overactivation of the striatonigral direct pathway.

SUBMITTER: Marti M 

PROVIDER: S-EPMC6794016 | biostudies-literature | 2012 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Nociceptin/orphanin FQ receptor agonists attenuate L-DOPA-induced dyskinesias.

Marti Matteo M   Rodi Donata D   Li Qin Q   Guerrini Remo R   Fasano Stefania S   Morella Ilaria I   Tozzi Alessandro A   Brambilla Riccardo R   Calabresi Paolo P   Simonato Michele M   Bezard Erwan E   Morari Michele M  

The Journal of neuroscience : the official journal of the Society for Neuroscience 20121101 46


In the present study we investigated whether the neuropeptide nociceptin/orphanin FQ (N/OFQ), previously implicated in the pathogenesis of Parkinson's disease, also affects L-DOPA-induced dyskinesia. In striatal slices of naive rodents, N/OFQ (0.1-1 μm) prevented the increase of ERK phosphorylation and the loss of depotentiation of synaptic plasticity induced by the D1 receptor agonist SKF38393 in spiny neurons. In vivo, exogenous N/OFQ (0.03-1 nmol, i.c.v.) or a synthetic N/OFQ receptor agonist  ...[more]

Similar Datasets

| S-EPMC3257111 | biostudies-literature
| S-EPMC5811622 | biostudies-literature
| S-EPMC3582300 | biostudies-other
2020-11-14 | GSE161412 | GEO
| S-EPMC5382891 | biostudies-literature
| S-EPMC5555400 | biostudies-other
| S-EPMC3356928 | biostudies-literature
| S-EPMC4813427 | biostudies-literature
| S-EPMC8612119 | biostudies-literature
| S-EPMC3242299 | biostudies-literature